David Price

Inclusion of Cultural and Linguistic Diversity in COVID-19 Public Health Research: Research Design Adaptations to Seek Different Perspectives in Victoria, Australia.

Lisa Gibbs, Alexander J Thomas, Alison Coelho, Adil Al-Qassas, Karen Block, Niamh Meagher, Limya Eisa, Stephanie Fletcher-Lartey, Tianhui Ke, Phoebe Kerr, Edwin Jit Leung Kwong, Colin MacDougall, Deng Malith, Katitza Marinkovic Chavez, Deborah Osborne, David J Price, Freya Shearer, Mark Stoove, Kathryn Young, Yanqin Zhang, et al.

Journal article  |  2023  |  Int J Environ Res Public Health

Participation of people from culturally and linguistically diverse (CALD) communities in public health research is often limited b..

Anticoagulation Strategies in Non–Critically Ill Patients with Covid-19

Zoe K McQuilten, Balasubramanian Venkatesh, Vivekanand Jha, Jason Roberts, Susan C Morpeth, James A Totterdell, Grace M McPhee, John Abraham, Niraj Bam, Methma Bandara, Ashpak K Bangi, Lauren A Barina, Bhupendra K Basnet, Hasan Bhally, Khema R Bhusal, Umesh Bogati, Asha C Bowen, Andrew J Burke, Devasahayam J Christopher, Sanjeev D Chunilal, et al.

Journal article  |  2023  |  NEJM Evidence

A modelling approach to estimate the transmissibility of SARS-CoV-2 during periods of high, low, and zero case incidence.

Nick Golding, David J Price, Gerard Ryan, Jodie McVernon, James M McCaw, Freya M Shearer

Journal article  |  2023  |  Elife

Against a backdrop of widespread global transmission, a number of countries have successfully brought large outbreaks of COVID-19 ..

Real-time analysis of hospital length of stay in a mixed SARS-CoV-2 Omicron and Delta epidemic in New South Wales, Australia

Ruarai JJ Tobin, James GG Wood, Duleepa Jayasundara, Grant Sara, Camelia RR Walker, Genevieve EE Martin, James MM McCaw, Freya MM Shearer, David JJ Price

Journal article  |  2023  |  BMC INFECTIOUS DISEASES

BACKGROUND: The distribution of the duration that clinical cases of COVID-19 occupy hospital beds (the 'length of stay') is a key ..

HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy.

Jennifer M Zerbato, Anchalee Avihingsanon, Kasha P Singh, Wei Zhao, Claire Deleage, Elias Rosen, Mackenzie L Cottrell, Ajantha Rhodes, Ashanti Dantanarayana, Carolin Tumpach, Surekha Tennakoon, Megan Crane, David J Price, Sabine Braat, Hugh Mason, Michael Roche, Angela DM Kashuba, Peter A Revill, Jennifer Audsley, Sharon R Lewin

Journal article  |  2023  |  EBioMedicine

BACKGROUND: HIV can infect multiple cells in the liver including hepatocytes, Kupffer cells and infiltrating T cells, but whether ..

ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial.

Justin T Denholm, Balasubramanian Venkatesh, Joshua Davis, Asha C Bowen, Naomi E Hammond, Vivekanand Jha, Grace McPhee, Zoe McQuilten, Matthew VN O'Sullivan, David Paterson, David Price, Megan Rees, Jason Roberts, Mark Jones, James Totterdell, Thomas Snelling, Nanette Trask, Susan Morpeth, Steven Yc Tong, undefined ASCOT ADAPT investigators

Journal article  |  2022  |  Trials

BACKGROUND: SARS-CoV-2 infection is associated with a significant risk of hospitalisation, death, and prolonged impact on quality ..

Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B

Josef Wagner, Lilly Yuen, Margaret Littlejohn, Vitina Sozzi, Kathy Jackson, Ross Martin, Thomas Aeschbacher, Vithika Suri, Susanna K Tan, Becket Feierbach, Anuj Gaggar, Patrick Marcellin, Maria Buti Ferret, Harry LA Janssen, Ed Gane, Niamh Meagher, David J Price, Darren Wong, Alexander T Thompson, Peter A Revill

Journal article  |  2022  |  ALIMENTARY PHARMACOLOGY & THERAPEUTICS

BACKGROUNDS AND AIMS: We investigated associations between hepatitis B virus (HBV) genome-length haplotype number (HN) at baseline..

Learnings from the Australian first few X household transmission project for COVID-19

Adrian J Marcato, Andrew J Black, Camelia R Walker, Dylan Morris, Niamh Meagher, David J Price, Jodie McVernon

Journal article  |  2022  |  LANCET REGIONAL HEALTH-WESTERN PACIFIC

BACKGROUND: First Few "X" (FFX) studies provide a platform to collect the required epidemiological, clinical and virological data ..

Whole genome sequencing for tuberculosis in Victoria, Australia: A genomic implementation study from 2017 to 2020

Katie Dale, Maria Globan, Kristy Horan, Norelle Sherry, Susan Ballard, Ee Laine Tay, Simone Bittmann, Niamh Meagher, David J Price, Benjamin P Howden, Deborah A Williamson, Justin Denholm

Journal article  |  2022  |  LANCET REGIONAL HEALTH-WESTERN PACIFIC

BACKGROUND: Whole genome sequencing (WGS) is increasingly used by tuberculosis (TB) programs to monitor Mycobacterium tuberculosis..

The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe

Steven YC Tong, Jocelyn Mora, Asha C Bowen, Matthew P Cheng, Nick Daneman, Anna L Goodman, George S Heriot, Todd C Lee, Roger J Lewis, David C Lye, Robert K Mahar, Julie Marsh, Anna McGlothlin, Zoe McQuilten, Susan C Morpeth, David L Paterson, David J Price, Jason A Roberts, J Owen Robinson, Sebastiaan J van Hal, et al.

Journal article  |  2022  |  CLINICAL INFECTIOUS DISEASES

Staphylococcus aureus bloodstream (SAB) infection is a common and severe infectious disease, with a 90-day mortality of 15%-30%. D..